Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?

by Annalisa Chiappella, Jennifer Crombie, Anna Guidetti, Umberto Vitolo, Philippe Armand, Paolo Corradini
Published 2019-10-01

The Incidence of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

by Jisun Hwang, Chong Hyun Suh, Kyung Won Kim, Ho Sung Kim, Philippe Armand, Raymond Y. Huang, Jeffrey P. Guenette
Published 2021-04-01

P1067: ESTIMATING THE RELATIVE EFFICACY OF FAVEZELIMAB WHEN USED IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH PD-1–REFRACTORY CLASSICAL HODGKIN LYMPHOMA

by Philippe Armand, Pier Luigi Zinzani, John Timmerman, Nathalie Johnson, David Lavie, Kannan Thiagarajan, Brian Topp, Pallavi Pillai, Alex F. Herrera
Published 2023-08-01

Donor and recipient sex in allogeneic stem cell transplantation: what really matters

by Haesook T. Kim, Mei-Jie Zhang, Ann E. Woolfrey, Andrew St. Martin, Junfang Chen, Wael Saber, Miguel-Angel Perales, Philippe Armand, Mary Eapen
Published 2016-10-01

Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantation

by Natasha Kekre, Haesook T. Kim, Gita Thanarajasingam, Philippe Armand, Joseph H. Antin, Corey Cutler, Sarah Nikiforow, Vincent T. Ho, John Koreth, Edwin P. Alyea, Robert J. Soiffer
Published 2015-09-01

Venous thromboembolism is associated with graft-versus-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation

by Natasha Kekre, Haesook T. Kim, Vincent T. Ho, Corey Cutler, Philippe Armand, Sarah Nikiforow, Edwin P. Alyea, Robert J. Soiffer, Joseph H. Antin, Jean M. Connors, John Koreth
Published 2017-07-01

Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell...

by Paul S. Martin, Shuli Li, Sarah Nikiforow, Edwin P. Alyea, Joseph H. Antin, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Natasha Kekre, John Koreth, C. John Luckey, Jerome Ritz, Robert J. Soiffer
Published 2016-04-01

A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation

by Sarah Nikiforow, Haesook T. Kim, Heather Daley, Carol Reynolds, Kyle Thomas Jones, Philippe Armand, Vincent T. Ho, Edwin P. Alyea, Corey S. Cutler, Jerome Ritz, Joseph H. Antin, Robert J. Soiffer, John Koreth
Published 2016-10-01

Hepatitis E outbreak in the health district of Bocaranga-Koui, Central African Republic, 2018–2019

by Marina Prisca de Marguerite Nombot-Yazenguet, Joël Wilfried Doté, Giscard Wilfried Koyaweda, Philippe Armand Zemingui-Bembete, Benjamin Selekon, Ulrich Vickos, Alexandre Manirakiza, Emmanuel Nakoune, Ionela Gouandjika-Vasilache, Narcisse Patrice Joseph Komas
Published 2024-02-01

Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma

by Jeffrey A. Barnes, Eric Jacobsen, Yang Feng, Arnold Freedman, Ephraim P. Hochberg, Ann S. LaCasce, Philippe Armand, Robin Joyce, Aliyah R. Sohani, Scott J. Rodig, Donna Neuberg, David C. Fisher, Jeremy S. Abramson
Published 2013-04-01

P061: Safety and Dose-Expansion Study of Combination Favezelimab (anti–LAG-3) Plus Pembrolizumab in Anti–PD-1–Naive Patients With Relapsed or Refractory Classical Hodgkin Lymphoma...

by Peter Borchmann, Nathalie A. Johnson, David Lavie, Gareth Gregory, Alex F. Herrera, Leonard Minuk, Vladan Vucinic, Philippe Armand, Abraham Avigdor, Robin Gasiorowski, Yair Herishanu, Colm Keane, John Kuruvilla, John Palcza, Pallavi Pillai, Akash Nahar, John Timmerman
Published 2022-10-01

P1065: UPDATED RESULTS FROM AN OPEN-LABEL PHASE 1/2 STUDY OF FAVEZELIMAB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANTI–PD-1–NAIVE RELAPSED OR REFRACTORY CLASSICAL HODGKIN...

by Nathalie Johnson, David Lavie, Peter Borchmann, Gareth Gregory, Alex F. Herrera, Leonard Minuk, Vladan Vucinic, Philippe Armand, Abraham Avigdor, Robin Gasiorowski, Yair Herishanu, Colm Keane, John Kuruvilla, Rachel Marceau West, Pallavi Pillai, Patricia Marinello, John Timmerman
Published 2023-08-01

Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors

by Deepti Gadi, Stephen P. Martindale, Pui Yan Chiu, Jasneet Khalsa, Pei-Hsuan Chen, Stacey M. Fernandes, Zixu Wang, Svitlana Tyekucheva, John-Hanson Machado, David C. Fisher, Philippe Armand, Matthew S. Davids, Scott Rodig, Barbara Sherry, Jennifer R. Brown
Published 2023-02-01

Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy

by Jennifer L. Crombie, Caron A. Jacobson, Robert Redd, Geoffrey Shouse, Alex F. Herrera, Victor A. Chow, Jordan Gauthier, Erin Mullane, Kirk Cahill, Justin Kline, Jason Romancik, Jonathon B. Cohen, Anna Saucier, Roch Houot, Philippe Armand, Brian Hess
Published 2023-06-01

Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation

by Kazuyuki Murase, Haesook T. Kim, O.R. Gregory Bascug, Yutaka Kawano, Jeremy Ryan, Ken-ichi Matsuoka, Matthew S. Davids, John Koreth, Vincent T. Ho, Corey Cutler, Philippe Armand, Edwin P. Alyea, Bruce R. Blazar, Joseph H. Antin, Robert J. Soiffer, Anthony Letai, Jerome Ritz
Published 2014-09-01

A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

by Jennifer R. Brown, Bradley Messmer, Lillian Werner, Matthew S. Davids, Evgeny Mikler, Jeffrey G. Supko, David C. Fisher, Ann S. LaCasce, Philippe Armand, Eric Jacobsen, Virginia Dalton, Bethany Tesar, Stacey M. Fernandes, Sean McDonough, Jerome Ritz, Laura Rassenti, Thomas J. Kipps, Donna Neuberg, Arnold S. Freedman
Published 2013-06-01

Comparison of whole‐genome and immunoglobulin‐based circulating tumor DNA assays in diffuse large B‐cell lymphoma

by Reid W. Merryman, Justin Rhoades, Kan Xiong, Robert A. Redd, Katherine Antel, Hyun Hwan An, Mikaela McDonough, Liliana Guerrero, Andela Crnjac, Sainetra Sridhar, Timothy Blewett, Ju Cheng, Parastoo B. Dahi, Yago Nieto, Robin M. Joyce, Yi‐Bin Chen, Alex F. Herrera, Philippe Armand, Mark Murakami, Viktor A. Adalsteinsson
Published 2024-04-01

Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results

by John Koreth, Haesook T. Kim, Paulina B. Lange, Samuel J. Poryanda, Carol G. Reynolds, Sharmila Chamling Rai, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Brett Glotzbecker, Rushdia Yusuf, Sarah Nikiforow, Yi-Bin Chen, Bimalangshu Dey, Malgorzata McMasters, Jerome Ritz, Bruce R. Blazar, Robert J. Soiffer, Joseph H. Antin, Edwin P. Alyea
Published 2018-03-01

1423 Novel immunotherapy based on commensal-derived peptides to drive an effective CD8 T Cell response against selected tumor-associated antigens (TAAs)

by Ana Maia, Stephen Ansell, Philippe Armand, Cécile Gouttefangeas, Jonathan W Friedberg, Alice Talpin, Jerome Kervevan, Lucie Aubergeon, Tifanny Mersceman Blanc, Diana Bachrouche, Chloé Ventujol, Léa Bernard, Amandine Manteau, Jose Villasboas, Antonello Pinto, Francesc Bosch, Ramon García-Sanz, Carlos Grande Garcia, Stephen D Smith, Luca Arcaini, Reid Merryman, Pier Zinzani, Christophe Bonny, Laurent Chene, Joao Gamelas Magalhaes
Published 2023-11-01

Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma

by Reid W. Merryman, Laure Michaud, Robert Redd, Patrizia Mondello, Hyesun Park, Gabriela Spilberg, Matthew Robertson, Eleanor Taranto, Gulrayz Ahmed, Matthew Chase, Erin Jeter, Inhye E. Ahn, Jennifer R. Brown, Jennifer Crombie, Matthew S. Davids, David C. Fisher, Eric Jacobsen, Caron A. Jacobson, Austin I. Kim, Ann S. LaCasce, Samuel Y. Ng, Oreofe O. Odejide, Erin M. Parry, Gilles Salles, Andrew D. Zelenetz, Philippe Armand, Heiko Schöder, Heather Jacene
Published 2023-02-01